Results 21 to 30 of about 4,376,584 (354)

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms

open access: yesInternational Journal of Molecular Sciences, 2021
Interstitial lung diseases (ILDs) comprise different fibrotic lung disorders characterized by cellular proliferation, interstitial inflammation, and fibrosis.
P. Montero   +3 more
semanticscholar   +1 more source

Clustering of lung diseases in the family of interstitial lung disease patients

open access: yesBMC Pulmonary Medicine, 2022
Background The presence of familial interstitial lung disease (ILD) has been found to predict development of progressive pulmonary fibrosis. However, the role of non-ILD lung diseases in ILD patients’ families has not yet been investigated.
Michelle Terwiel   +2 more
doaj   +1 more source

Home monitoring in interstitial lung diseases.

open access: yesThe Lancet Respiratory Medicine, 2022
The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with ...
M. Wijsenbeek   +12 more
semanticscholar   +1 more source

No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis

open access: yesERJ Open Research, 2023
Background Telomere dysfunction can underly the development of idiopathic pulmonary fibrosis (IPF), and recent work suggests that patients with telomere syndromes might benefit from treatment with androgens, such as danazol.
Thijs W. Hoffman   +4 more
doaj   +1 more source

Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2022
Rationale Sustained activation of lung fibroblasts and the resulting oversynthesis of the extracellular matrix are detrimental events for patients with interstitial lung diseases (ILDs).
Peng-Hui Yang   +20 more
semanticscholar   +1 more source

Decreased Survival and Lung Function in Progressive Pulmonary Fibrosis

open access: yesMedicina, 2023
Background and Objectives: Progressive pulmonary fibrosis (PPF) is a recently described term reserved for patients with fibrotic ILD other than idiopathic pulmonary fibrosis (IPF) with fast clinical deterioration. Here, survival and prognostic biomarkers
Mark G. J. P. Platenburg   +3 more
doaj   +1 more source

Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases

open access: yesJournal of Clinical Medicine, 2022
Interstitial lung diseases (ILD) or diffuse parenchymal lung diseases (DPLD) comprise a large number of disorders. Disease definition and classification allow advanced and personalized judgements on clinical disease, risks for genetic or environmental ...
M. Griese
semanticscholar   +1 more source

Interstitial lung disease [PDF]

open access: yesEuropean Respiratory Review, 2014
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M.   +5 more
openaire   +4 more sources

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis [PDF]

open access: yes, 2019
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome.
박무석, 이상훈
core   +2 more sources

Nintedanib: A Review in Fibrotic Interstitial Lung Diseases

open access: yesDrugs, 2021
Progressive fibrosing interstitial lung diseases (ILDs) involve similar pathophysiological processes, indicating the potential for common approaches to treatment.
Yvette N. Lamb
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy